25 XP   0   0   10

Shin Poong Pharm.Co.Ltd.
Buy, Hold or Sell?

Let's analyse Shin Poong Pharm.Co.Ltd. together

PenkeI guess you are interested in Shin Poong Pharm.Co.Ltd.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Shin Poong Pharm.Co.Ltd.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Shin Poong Pharm.Co.Ltd.

I send you an email if I find something interesting about Shin Poong Pharm.Co.Ltd..

Quick analysis of Shin Poong Pharm.Co.Ltd. (30 sec.)










What can you expect buying and holding a share of Shin Poong Pharm.Co.Ltd.? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
32.5%

What is your share worth?

Current worth
₩6,239.12
Expected worth in 1 year
₩5,593.30
How sure are you?
45.0%

+ What do you gain per year?

Total Gains per Share
₩-645.82
Return On Investment
-4.1%

For what price can you sell your share?

Current Price per Share
₩15,820.00
Expected price per share
₩14,070 - ₩22,150
How sure are you?
50%

1. Valuation of Shin Poong Pharm.Co.Ltd. (5 min.)




Live pricePrice per Share (EOD)

₩15,820.00

Intrinsic Value Per Share

₩-18,109.91 - ₩-2,591.67

Total Value Per Share

₩-11,870.79 - ₩3,647.45

2. Growth of Shin Poong Pharm.Co.Ltd. (5 min.)




Is Shin Poong Pharm.Co.Ltd. growing?

Current yearPrevious yearGrowGrow %
How rich?$215.1m$242.9m-$19.2m-8.6%

How much money is Shin Poong Pharm.Co.Ltd. making?

Current yearPrevious yearGrowGrow %
Making money-$7.1m-$5.3m-$1.8m-25.3%
Net Profit Margin-19.2%-15.3%--

How much money comes from the company's main activities?

3. Financial Health of Shin Poong Pharm.Co.Ltd. (5 min.)




What can you expect buying and holding a share of Shin Poong Pharm.Co.Ltd.? (5 min.)

Welcome investor! Shin Poong Pharm.Co.Ltd.'s management wants to use your money to grow the business. In return you get a share of Shin Poong Pharm.Co.Ltd..

What can you expect buying and holding a share of Shin Poong Pharm.Co.Ltd.?

First you should know what it really means to hold a share of Shin Poong Pharm.Co.Ltd.. And how you can make/lose money.

Speculation

The Price per Share of Shin Poong Pharm.Co.Ltd. is ₩15,820. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Shin Poong Pharm.Co.Ltd..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Shin Poong Pharm.Co.Ltd., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩6,239.12. Based on the TTM, the Book Value Change Per Share is ₩-161.45 per quarter. Based on the YOY, the Book Value Change Per Share is ₩-139.99 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Shin Poong Pharm.Co.Ltd..

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.110.0%-0.150.0%-0.100.0%-0.040.0%-0.020.0%
Usd Book Value Change Per Share-0.120.0%-0.110.0%-0.100.0%0.070.0%0.040.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.010.0%0.010.0%
Usd Total Gains Per Share-0.120.0%-0.110.0%-0.100.0%0.080.0%0.060.0%
Usd Price Per Share10.78-12.33-19.67-25.91-15.00-
Price to Earnings Ratio-23.56--22.90--57.93-423.96-258.48-
Price-to-Total Gains Ratio-92.10--111.83--229.70--210.61--42.96-
Price to Book Ratio2.47-2.71-3.98-5.41-3.41-
Price-to-Total Gains Ratio-92.10--111.83--229.70--210.61--42.96-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share11.074
Number of shares90
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share-0.110.07
Usd Total Gains Per Share-0.110.08
Gains per Quarter (90 shares)-10.177.53
Gains per Year (90 shares)-40.6930.12
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-41-5152520
20-81-92115050
30-122-133167580
40-163-1742199110
50-203-21526124140
60-244-25632149170
70-285-29737174200
80-325-33842199230
90-366-37947224260
100-407-42053248290

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%3.09.00.025.0%10.010.00.050.0%23.012.05.057.5%25.012.06.058.1%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%6.014.00.030.0%17.023.00.042.5%19.024.00.044.2%
Dividend per Share0.00.04.00.0%2.00.010.016.7%4.00.016.020.0%13.00.027.032.5%16.00.027.037.2%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%6.014.00.030.0%18.022.00.045.0%20.023.00.046.5%

Fundamentals of Shin Poong Pharm.Co.Ltd.

About Shin Poong Pharm.Co.Ltd.

Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; wound dressings; health functional food; and over the counter products. In addition, the company engages in business management and exports its products to approximately 50 countries. The company was founded in 1962 and is headquartered in Seoul, South Korea.

Fundamental data was last updated by Penke on 2024-03-24 11:20:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Shin Poong Pharm.Co.Ltd..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Shin Poong Pharm.Co.Ltd. earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Shin Poong Pharm.Co.Ltd. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -16.4% means that ₩-0.16 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Shin Poong Pharm.Co.Ltd.:

  • The MRQ is -16.4%. The company is making a huge loss. -2
  • The TTM is -19.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-16.4%TTM-19.2%+2.8%
TTM-19.2%YOY-15.3%-3.9%
TTM-19.2%5Y-6.0%-13.2%
5Y-6.0%10Y-3.0%-3.0%
1.1.2. Return on Assets

Shows how efficient Shin Poong Pharm.Co.Ltd. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Shin Poong Pharm.Co.Ltd. to the Drug Manufacturers - Specialty & Generic industry mean.
  • -2.1% Return on Assets means that Shin Poong Pharm.Co.Ltd. generated ₩-0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Shin Poong Pharm.Co.Ltd.:

  • The MRQ is -2.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.1%TTM-2.7%+0.7%
TTM-2.7%YOY-2.0%-0.8%
TTM-2.7%5Y-0.8%-1.9%
5Y-0.8%10Y-0.4%-0.4%
1.1.3. Return on Equity

Shows how efficient Shin Poong Pharm.Co.Ltd. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Shin Poong Pharm.Co.Ltd. to the Drug Manufacturers - Specialty & Generic industry mean.
  • -2.6% Return on Equity means Shin Poong Pharm.Co.Ltd. generated ₩-0.03 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Shin Poong Pharm.Co.Ltd.:

  • The MRQ is -2.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -3.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.6%TTM-3.2%+0.6%
TTM-3.2%YOY-2.2%-1.0%
TTM-3.2%5Y-0.9%-2.3%
5Y-0.9%10Y-0.4%-0.5%

1.2. Operating Efficiency of Shin Poong Pharm.Co.Ltd..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Shin Poong Pharm.Co.Ltd. is operating .

  • Measures how much profit Shin Poong Pharm.Co.Ltd. makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Shin Poong Pharm.Co.Ltd. to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Shin Poong Pharm.Co.Ltd.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-8.7%+8.7%
TTM-8.7%YOY-16.3%+7.6%
TTM-8.7%5Y-1.7%-6.9%
5Y-1.7%10Y0.2%-1.9%
1.2.2. Operating Ratio

Measures how efficient Shin Poong Pharm.Co.Ltd. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.82 means that the operating costs are ₩1.82 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Shin Poong Pharm.Co.Ltd.:

  • The MRQ is 1.822. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.021. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.822TTM1.021+0.801
TTM1.021YOY1.631-0.610
TTM1.0215Y1.434-0.413
5Y1.43410Y1.165+0.269

1.3. Liquidity of Shin Poong Pharm.Co.Ltd..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Shin Poong Pharm.Co.Ltd. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.97 means the company has ₩2.97 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Shin Poong Pharm.Co.Ltd.:

  • The MRQ is 2.966. The company is able to pay all its short-term debts. +1
  • The TTM is 4.375. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.966TTM4.375-1.409
TTM4.375YOY7.511-3.136
TTM4.3755Y4.297+0.078
5Y4.29710Y2.456+1.841
1.3.2. Quick Ratio

Measures if Shin Poong Pharm.Co.Ltd. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Shin Poong Pharm.Co.Ltd. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.24 means the company can pay off ₩1.24 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Shin Poong Pharm.Co.Ltd.:

  • The MRQ is 1.239. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 2.182. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.239TTM2.182-0.943
TTM2.182YOY4.613-2.431
TTM2.1825Y2.535-0.353
5Y2.53510Y1.750+0.785

1.4. Solvency of Shin Poong Pharm.Co.Ltd..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Shin Poong Pharm.Co.Ltd. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Shin Poong Pharm.Co.Ltd. to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.20 means that Shin Poong Pharm.Co.Ltd. assets are financed with 19.8% credit (debt) and the remaining percentage (100% - 19.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Shin Poong Pharm.Co.Ltd.:

  • The MRQ is 0.198. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.152. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.198TTM0.152+0.046
TTM0.152YOY0.104+0.048
TTM0.1525Y0.263-0.111
5Y0.26310Y0.377-0.114
1.4.2. Debt to Equity Ratio

Measures if Shin Poong Pharm.Co.Ltd. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Shin Poong Pharm.Co.Ltd. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 24.8% means that company has ₩0.25 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Shin Poong Pharm.Co.Ltd.:

  • The MRQ is 0.248. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.183. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.248TTM0.183+0.065
TTM0.183YOY0.117+0.066
TTM0.1835Y0.423-0.240
5Y0.42310Y0.702-0.279

2. Market Valuation of Shin Poong Pharm.Co.Ltd.

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Shin Poong Pharm.Co.Ltd. generates.

  • Above 15 is considered overpriced but always compare Shin Poong Pharm.Co.Ltd. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -23.56 means the investor is paying ₩-23.56 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Shin Poong Pharm.Co.Ltd.:

  • The EOD is -24.202. Based on the earnings, the company is expensive. -2
  • The MRQ is -23.560. Based on the earnings, the company is expensive. -2
  • The TTM is -22.900. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-24.202MRQ-23.560-0.643
MRQ-23.560TTM-22.900-0.660
TTM-22.900YOY-57.934+35.034
TTM-22.9005Y423.956-446.856
5Y423.95610Y258.479+165.477
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Shin Poong Pharm.Co.Ltd.:

  • The EOD is -17.597. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -17.129. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -21.997. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-17.597MRQ-17.129-0.467
MRQ-17.129TTM-21.997+4.868
TTM-21.997YOY17.375-39.372
TTM-21.9975Y69.859-91.857
5Y69.85910Y53.790+16.070
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Shin Poong Pharm.Co.Ltd. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 2.47 means the investor is paying ₩2.47 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Shin Poong Pharm.Co.Ltd.:

  • The EOD is 2.536. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.468. Based on the equity, the company is underpriced. +1
  • The TTM is 2.709. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.536MRQ2.468+0.067
MRQ2.468TTM2.709-0.240
TTM2.709YOY3.977-1.268
TTM2.7095Y5.412-2.703
5Y5.41210Y3.407+2.005
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Shin Poong Pharm.Co.Ltd. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---167.212-161.455-3%-139.993-16%98.576-270%60.493-376%
Book Value Per Share--6239.1236486.862-4%7044.307-11%6093.638+2%5117.918+22%
Current Ratio--2.9664.375-32%7.511-61%4.297-31%2.456+21%
Debt To Asset Ratio--0.1980.152+30%0.104+90%0.263-25%0.377-47%
Debt To Equity Ratio--0.2480.183+36%0.117+112%0.423-41%0.702-65%
Dividend Per Share----0%-0%20.930-100%19.030-100%
Eps---163.415-211.885+30%-145.644-11%-63.089-61%-29.254-82%
Free Cash Flow Per Share---224.759-229.439+2%-186.717-17%-103.590-54%-8.038-96%
Free Cash Flow To Equity Per Share---224.759-235.662+5%-194.954-13%-5.833-97%65.211-445%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.875+14%
Intrinsic Value_10Y_max---2591.675--------
Intrinsic Value_10Y_min---18109.911--------
Intrinsic Value_1Y_max---65.183--------
Intrinsic Value_1Y_min---1048.999--------
Intrinsic Value_3Y_max---344.096--------
Intrinsic Value_3Y_min---3833.715--------
Intrinsic Value_5Y_max---801.739--------
Intrinsic Value_5Y_min---7344.422--------
Market Cap779467220000.000+3%758773846600.000867909175835.000-13%1384515914900.000-45%1824432357307.000-58%1057554352642.565-28%
Net Profit Margin---0.164-0.192+17%-0.153-7%-0.060-64%-0.030-82%
Operating Margin----0.0870%-0.1630%-0.0170%0.002-100%
Operating Ratio--1.8221.021+78%1.631+12%1.434+27%1.165+56%
Pb Ratio2.536+3%2.4682.709-9%3.977-38%5.412-54%3.407-28%
Pe Ratio-24.202-3%-23.560-22.900-3%-57.934+146%423.956-106%258.479-109%
Price Per Share15820.000+3%15400.00017615.000-13%28100.000-45%37009.500-58%21434.500-28%
Price To Free Cash Flow Ratio-17.597-3%-17.129-21.997+28%17.375-199%69.859-125%53.790-132%
Price To Total Gains Ratio-94.610-3%-92.098-111.835+21%-229.703+149%-210.606+129%-42.964-53%
Quick Ratio--1.2392.182-43%4.613-73%2.535-51%1.750-29%
Return On Assets---0.021-0.027+31%-0.020-6%-0.008-60%-0.004-81%
Return On Equity---0.026-0.032+22%-0.022-16%-0.009-66%-0.004-85%
Total Gains Per Share---167.212-161.455-3%-139.993-16%119.505-240%79.524-310%
Usd Book Value--215185616.884223730049.251-4%242956177.065-11%210589322.228+2%177150864.012+21%
Usd Book Value Change Per Share---0.117-0.113-3%-0.098-16%0.069-270%0.042-376%
Usd Book Value Per Share--4.3674.541-4%4.931-11%4.266+2%3.583+22%
Usd Dividend Per Share----0%-0%0.015-100%0.013-100%
Usd Eps---0.114-0.148+30%-0.102-11%-0.044-61%-0.020-82%
Usd Free Cash Flow---7751861.327-7913274.506+2%-6439801.636-17%-3566047.002-54%-254805.901-97%
Usd Free Cash Flow Per Share---0.157-0.161+2%-0.131-17%-0.073-54%-0.006-96%
Usd Free Cash Flow To Equity Per Share---0.157-0.165+5%-0.136-13%-0.004-97%0.046-445%
Usd Market Cap545627054.000+3%531141692.620607536423.085-13%969161140.430-45%1277102650.115-58%740288046.850-28%
Usd Price Per Share11.074+3%10.78012.331-13%19.670-45%25.907-58%15.004-28%
Usd Profit---5636122.170-7188399.811+28%-5372838.102-5%-2209452.882-61%-1040559.807-82%
Usd Revenue--34394054.87736647107.746-6%35035691.450-2%34547112.0240%34507721.3170%
Usd Total Gains Per Share---0.117-0.113-3%-0.098-16%0.084-240%0.056-310%
 EOD+5 -3MRQTTM+15 -17YOY+4 -285Y+10 -2410Y+11 -25

3.2. Fundamental Score

Let's check the fundamental score of Shin Poong Pharm.Co.Ltd. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-24.202
Price to Book Ratio (EOD)Between0-12.536
Net Profit Margin (MRQ)Greater than0-0.164
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.239
Current Ratio (MRQ)Greater than12.966
Debt to Asset Ratio (MRQ)Less than10.198
Debt to Equity Ratio (MRQ)Less than10.248
Return on Equity (MRQ)Greater than0.15-0.026
Return on Assets (MRQ)Greater than0.05-0.021
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Shin Poong Pharm.Co.Ltd. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5064.146
Ma 20Greater thanMa 5013,195.500
Ma 50Greater thanMa 10012,632.200
Ma 100Greater thanMa 20012,849.700
OpenGreater thanClose16,150.000
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-09-302022-12-312023-03-312023-06-302023-09-30
Long-term Assets Other  0-628,436-628,4362,452-625,984128,638-497,346534,50837,162
Operating Income  19,218,22083,111,210102,329,430-83,180,62719,148,8032,752,20921,901,012-32,776,221-10,875,209



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets383,428,831
Total Liabilities76,020,807
Total Stockholder Equity306,182,058
 As reported
Total Liabilities 76,020,807
Total Stockholder Equity+ 306,182,058
Total Assets = 383,428,831

Assets

Total Assets383,428,831
Total Current Assets214,698,046
Long-term Assets168,730,785
Total Current Assets
Cash And Cash Equivalents 58,917,842
Short-term Investments 17,029,538
Net Receivables 72,630,573
Inventory 51,806,592
Other Current Assets 39,748
Total Current Assets  (as reported)214,698,046
Total Current Assets  (calculated)200,424,294
+/- 14,273,752
Long-term Assets
Property Plant Equipment 120,464,001
Intangible Assets 6,098,826
Long-term Assets Other 37,162
Long-term Assets  (as reported)168,730,785
Long-term Assets  (calculated)126,599,988
+/- 42,130,796

Liabilities & Shareholders' Equity

Total Current Liabilities72,386,155
Long-term Liabilities3,634,651
Total Stockholder Equity306,182,058
Total Current Liabilities
Short Long Term Debt 45,000,000
Accounts payable 11,707,180
Other Current Liabilities 3,214,888
Total Current Liabilities  (as reported)72,386,155
Total Current Liabilities  (calculated)59,922,068
+/- 12,464,087
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,469,999
Long-term Liabilities Other 494,228
Long-term Liabilities  (as reported)3,634,651
Long-term Liabilities  (calculated)1,964,227
+/- 1,670,424
Total Stockholder Equity
Retained Earnings 91,745,520
Total Stockholder Equity (as reported)306,182,058
Total Stockholder Equity (calculated)91,745,520
+/- 214,436,538
Other
Capital Stock27,592,495
Common Stock Shares Outstanding 49,271
Net Invested Capital 350,082,058
Net Working Capital 142,311,891
Property Plant and Equipment Gross 263,809,590



Balance Sheet

Currency in KRW. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
> Total Assets 
391,550,239
400,296,253
404,296,216
398,354,727
400,936,768
404,819,155
408,583,950
409,295,444
406,087,935
405,334,709
405,396,843
410,730,240
404,820,447
429,851,364
422,878,213
416,488,338
402,577,792
400,680,155
399,683,711
390,629,924
382,685,877
391,647,359
390,327,951
385,129,325
392,884,671
395,509,541
390,278,757
380,113,704
390,237,607
390,560,900
602,603,322
487,149,865
465,806,713
427,096,821
416,053,208
392,584,583
388,625,426
388,369,515
380,402,946
361,536,058
387,416,384
377,433,587
383,428,831
383,428,831377,433,587387,416,384361,536,058380,402,946388,369,515388,625,426392,584,583416,053,208427,096,821465,806,713487,149,865602,603,322390,560,900390,237,607380,113,704390,278,757395,509,541392,884,671385,129,325390,327,951391,647,359382,685,877390,629,924399,683,711400,680,155402,577,792416,488,338422,878,213429,851,364404,820,447410,730,240405,396,843405,334,709406,087,935409,295,444408,583,950404,819,155400,936,768398,354,727404,296,216400,296,253391,550,239
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
235,778,453
224,126,819
223,337,778
222,624,142
218,828,497
218,821,072
229,914,238
230,810,807
228,782,227
233,442,421
232,793,183
229,531,505
219,191,528
233,816,696
231,008,480
445,599,344
332,811,722
317,618,490
280,774,891
269,132,892
227,231,841
224,052,584
222,291,205
215,509,414
196,541,781
222,738,324
209,514,996
214,698,046
214,698,046209,514,996222,738,324196,541,781215,509,414222,291,205224,052,584227,231,841269,132,892280,774,891317,618,490332,811,722445,599,344231,008,480233,816,696219,191,528229,531,505232,793,183233,442,421228,782,227230,810,807229,914,238218,821,072218,828,497222,624,142223,337,778224,126,819235,778,453000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,094,250
19,151,520
19,761,739
22,132,438
19,422,304
26,513,142
24,648,181
27,676,580
37,168,872
33,954,757
27,334,872
21,599,635
23,374,208
27,325,322
27,245,164
245,367,025
55,802,611
63,870,295
54,405,917
51,657,446
27,636,741
30,131,445
33,565,782
38,379,759
41,690,733
49,181,819
48,121,764
58,917,842
58,917,84248,121,76449,181,81941,690,73338,379,75933,565,78230,131,44527,636,74151,657,44654,405,91763,870,29555,802,611245,367,02527,245,16427,325,32223,374,20821,599,63527,334,87233,954,75737,168,87227,676,58024,648,18126,513,14219,422,30422,132,43819,761,73919,151,52016,094,250000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24,902,278
18,464,858
18,108,677
18,293,106
18,755,232
19,286,649
13,755,226
9,318,761
9,616,033
38,469,875
42,925,301
45,879,249
43,069,078
48,809,845
47,299,299
47,726,156
134,836,740
108,979,351
82,328,866
82,867,745
65,065,032
54,089,727
50,238,152
39,309,367
14,225,817
30,668,036
24,659,408
17,029,538
17,029,53824,659,40830,668,03614,225,81739,309,36750,238,15254,089,72765,065,03282,867,74582,328,866108,979,351134,836,74047,726,15647,299,29948,809,84543,069,07845,879,24942,925,30138,469,8759,616,0339,318,76113,755,22619,286,64918,755,23218,293,10618,108,67718,464,85824,902,278000000000000000
       Net Receivables 
142,311,662
149,142,872
148,328,578
145,647,947
145,537,917
145,103,940
156,750,986
157,859,249
155,739,217
154,079,076
153,448,258
156,273,399
159,559,157
158,880,133
155,727,866
151,791,211
143,783,204
143,464,626
137,195,901
132,478,885
122,690,480
124,692,155
122,695,097
115,792,544
111,757,691
109,609,872
108,849,727
101,771,208
101,283,669
100,171,212
95,776,196
91,013,889
91,110,930
93,338,805
84,808,599
84,159,383
84,135,078
83,642,247
84,684,865
90,575,586
75,802,941
83,878,485
72,630,573
72,630,57383,878,48575,802,94190,575,58684,684,86583,642,24784,135,07884,159,38384,808,59993,338,80591,110,93091,013,88995,776,196100,171,212101,283,669101,771,208108,849,727109,609,872111,757,691115,792,544122,695,097124,692,155122,690,480132,478,885137,195,901143,464,626143,783,204151,791,211155,727,866158,880,133159,559,157156,273,399153,448,258154,079,076155,739,217157,859,249156,750,986145,103,940145,537,917145,647,947148,328,578149,142,872142,311,662
       Other Current Assets 
436,480
651,942
1,082,467
590,265
997,060
278,704
1,180,153
692,473
2,885,776
1,427,934
2,260,521
863,530
718,460
849,951
1,135,487
783,818
797,441
882,726
1,217,082
942,799
1,458,287
6,019,318
5,429,686
1,142,022
1,020,588
694,115
935,561
1,358,344
1,339,325
1,292,666
1,240,329
1,174,219
1,223,760
1,242,395
1,253,917
1,763,703
4,503,065
1,429,458
4,592,969
2,146,888
35,587
1,380,916
39,748
39,7481,380,91635,5872,146,8884,592,9691,429,4584,503,0651,763,7031,253,9171,242,3951,223,7601,174,2191,240,3291,292,6661,339,3251,358,344935,561694,1151,020,5881,142,0225,429,6866,019,3181,458,287942,7991,217,082882,726797,441783,8181,135,487849,951718,460863,5302,260,5211,427,9342,885,776692,4731,180,153278,704997,060590,2651,082,467651,942436,480
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
159,442,251
162,716,358
160,747,252
160,922,175
156,420,911
159,552,420
157,003,978
154,338,143
148,188,223
146,321,929
146,920,316
165,352,742
164,572,842
166,078,310
164,893,531
164,994,277
164,678,060
167,918,590
168,730,785
168,730,785167,918,590164,678,060164,994,277164,893,531166,078,310164,572,842165,352,742146,920,316146,321,929148,188,223154,338,143157,003,978159,552,420156,420,911160,922,175160,747,252162,716,358159,442,251000000000000000000000000
       Property Plant Equipment 
160,698,713
161,408,133
163,561,627
161,697,213
161,107,802
160,666,907
159,740,470
159,941,355
157,938,755
156,054,717
154,357,129
152,192,209
150,286,214
148,102,393
145,963,894
144,268,730
142,388,081
140,726,841
139,309,204
138,192,046
135,608,404
133,521,899
131,633,197
130,504,647
132,377,744
131,983,881
133,203,527
130,942,363
130,219,340
127,819,208
125,616,671
124,177,497
122,524,390
120,833,243
119,569,124
116,883,611
116,229,327
116,780,317
116,008,150
113,759,902
114,421,365
119,295,518
120,464,001
120,464,001119,295,518114,421,365113,759,902116,008,150116,780,317116,229,327116,883,611119,569,124120,833,243122,524,390124,177,497125,616,671127,819,208130,219,340130,942,363133,203,527131,983,881132,377,744130,504,647131,633,197133,521,899135,608,404138,192,046139,309,204140,726,841142,388,081144,268,730145,963,894148,102,393150,286,214152,192,209154,357,129156,054,717157,938,755159,941,355159,740,470160,666,907161,107,802161,697,213163,561,627161,408,133160,698,713
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,929,175
17,505,626
17,278,033
19,081,133
17,490,612
12,487,305
12,415,380
12,846,193
10,096,851
11,479,697
14,136,933
10,840,848
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000010,840,84814,136,93311,479,69710,096,85112,846,19312,415,38012,487,30517,490,61219,081,13317,278,03317,505,62617,929,175000000000000000
       Intangible Assets 
11,258,271
11,449,310
11,263,281
15,950,591
15,899,059
15,857,576
15,290,781
14,588,632
13,875,296
13,164,122
12,526,959
12,173,654
12,004,176
11,840,007
11,601,503
11,275,393
11,458,760
11,582,453
11,375,243
8,784,291
8,553,644
8,343,486
7,295,107
7,119,876
6,918,514
7,921,264
8,198,701
8,914,284
8,587,919
8,485,200
8,547,512
8,062,013
7,889,039
8,421,233
8,131,064
8,970,638
7,470,512
7,643,132
7,362,645
6,930,822
6,659,527
6,330,833
6,098,826
6,098,8266,330,8336,659,5276,930,8227,362,6457,643,1327,470,5128,970,6388,131,0648,421,2337,889,0398,062,0138,547,5128,485,2008,587,9198,914,2848,198,7017,921,2646,918,5147,119,8767,295,1078,343,4868,553,6448,784,29111,375,24311,582,45311,458,76011,275,39311,601,50311,840,00712,004,17612,173,65412,526,95913,164,12213,875,29614,588,63215,290,78115,857,57615,899,05915,950,59111,263,28111,449,31011,258,271
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
159,442,251
0
0
160,922,175
156,420,911
0
0
0
0
0
0
0
0
0
0
-628,436
-625,984
-497,346
37,162
37,162-497,346-625,984-628,4360000000000156,420,911160,922,17500159,442,251000000000000000000000000
> Total Liabilities 
197,987,252
212,930,506
216,111,089
207,569,403
215,522,115
216,442,665
214,353,118
217,781,069
216,691,424
217,896,225
212,655,539
215,868,889
209,889,544
194,977,691
189,358,686
199,639,525
186,473,235
180,032,099
175,941,623
175,500,791
173,005,677
179,078,732
177,064,115
173,471,103
179,399,732
178,688,227
174,567,065
170,985,479
178,974,064
176,745,651
219,485,350
112,819,609
99,217,386
59,776,921
49,234,504
38,025,375
39,320,291
43,141,070
41,174,722
30,777,771
62,772,023
61,786,835
76,020,807
76,020,80761,786,83562,772,02330,777,77141,174,72243,141,07039,320,29138,025,37549,234,50459,776,92199,217,386112,819,609219,485,350176,745,651178,974,064170,985,479174,567,065178,688,227179,399,732173,471,103177,064,115179,078,732173,005,677175,500,791175,941,623180,032,099186,473,235199,639,525189,358,686194,977,691209,889,544215,868,889212,655,539217,896,225216,691,424217,781,069214,353,118216,442,665215,522,115207,569,403216,111,089212,930,506197,987,252
   > Total Current Liabilities 
163,832,151
179,905,360
181,793,742
152,631,584
157,162,396
155,773,092
156,942,583
180,509,225
180,598,123
180,833,361
179,678,263
184,244,914
176,182,999
161,279,699
152,770,185
167,017,657
152,177,882
145,074,482
140,763,219
139,075,968
135,243,783
149,662,815
147,561,092
146,170,853
147,678,735
147,680,838
140,542,011
133,953,360
139,046,896
136,011,847
159,195,481
83,337,026
69,207,316
40,139,711
31,138,700
28,550,129
27,988,649
32,399,025
29,855,133
27,167,238
59,356,152
59,097,037
72,386,155
72,386,15559,097,03759,356,15227,167,23829,855,13332,399,02527,988,64928,550,12931,138,70040,139,71169,207,31683,337,026159,195,481136,011,847139,046,896133,953,360140,542,011147,680,838147,678,735146,170,853147,561,092149,662,815135,243,783139,075,968140,763,219145,074,482152,177,882167,017,657152,770,185161,279,699176,182,999184,244,914179,678,263180,833,361180,598,123180,509,225156,942,583155,773,092157,162,396152,631,584181,793,742179,905,360163,832,151
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
121,437,053
118,858,687
117,032,332
750,000
500,000
250,000
4,550,000
4,550,000
0
102,953,203
102,621,646
98,330,000
98,506,689
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000098,506,68998,330,000102,621,646102,953,20304,550,0004,550,000250,000500,000750,000117,032,332118,858,687121,437,053000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
121,437,053
118,858,687
117,032,332
750,000
500,000
250,000
4,550,000
4,550,000
0
102,953,203
102,621,646
98,330,000
98,506,689
96,532,749
96,313,388
77,477,567
150,166
5,920
9,979,802
162,271
248,111
0
138,637
0
0
30,000,000
30,000,000
45,000,000
45,000,00030,000,00030,000,00000138,6370248,111162,2719,979,8025,920150,16677,477,56796,313,38896,532,74998,506,68998,330,000102,621,646102,953,20304,550,0004,550,000250,000500,000750,000117,032,332118,858,687121,437,053000000000000000
       Accounts payable 
0
23,863,595
24,702,092
21,600,133
22,425,011
24,490,147
22,288,275
19,466,566
20,224,877
21,683,051
19,736,441
17,194,764
18,253,481
18,661,526
17,594,966
15,904,980
17,857,081
21,646,605
21,821,733
25,175,260
21,224,356
20,699,391
19,928,500
21,163,837
20,183,918
22,699,199
21,115,339
18,373,184
23,243,848
21,446,997
17,922,102
8,788,909
12,831,658
12,148,652
12,350,086
12,060,475
12,441,849
12,126,020
9,008,858
11,428,317
12,001,280
12,891,185
11,707,180
11,707,18012,891,18512,001,28011,428,3179,008,85812,126,02012,441,84912,060,47512,350,08612,148,65212,831,6588,788,90917,922,10221,446,99723,243,84818,373,18421,115,33922,699,19920,183,91821,163,83719,928,50020,699,39121,224,35625,175,26021,821,73321,646,60517,857,08115,904,98017,594,96618,661,52618,253,48117,194,76419,736,44121,683,05120,224,87719,466,56622,288,27524,490,14722,425,01121,600,13324,702,09223,863,5950
       Other Current Liabilities 
39,715,802
18,366,826
17,547,764
16,795,937
19,279,255
16,481,505
14,924,708
13,887,366
17,884,922
13,824,630
14,096,174
15,430,604
13,907,266
14,704,917
15,178,520
37,725,624
25,262,114
15,945,545
13,149,467
10,885,425
12,047,397
20,199,887
20,123,784
15,311,677
4,967,836
4,621,435
4,603,194
11,981,508
15,063,683
13,576,904
58,305,370
68,385,744
49,375,029
10,711,998
10,292,333
8,464,812
8,295,252
10,172,552
6,669,987
3,338,998
3,325,327
6,468,829
3,214,888
3,214,8886,468,8293,325,3273,338,9986,669,98710,172,5528,295,2528,464,81210,292,33310,711,99849,375,02968,385,74458,305,37013,576,90415,063,68311,981,5084,603,1944,621,4354,967,83615,311,67720,123,78420,199,88712,047,39710,885,42513,149,46715,945,54525,262,11437,725,62415,178,52014,704,91713,907,26615,430,60414,096,17413,824,63017,884,92213,887,36614,924,70816,481,50519,279,25516,795,93717,547,76418,366,82639,715,802
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
31,720,997
31,007,389
34,025,054
37,032,119
39,927,168
40,733,804
60,289,870
29,482,583
30,010,070
19,637,210
18,095,804
9,475,246
11,331,642
10,742,046
11,319,589
3,610,533
3,415,871
2,689,798
3,634,651
3,634,6512,689,7983,415,8713,610,53311,319,58910,742,04611,331,6429,475,24618,095,80419,637,21030,010,07029,482,58360,289,87040,733,80439,927,16837,032,11934,025,05431,007,38931,720,997000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-121,437,053
-118,858,687
-117,032,332
-750,000
-500,000
-250,000
-4,550,000
-4,550,000
0
-101,916,713
-101,745,168
-97,663,990
-98,072,874
784,454
956,976
1,176,921
1,635,104
1,544,525
1,384,895
1,229,614
932,602
1,580,203
2,128,205
2,301,705
1,928,274
1,608,609
1,366,188
1,469,999
1,469,9991,366,1881,608,6091,928,2742,301,7052,128,2051,580,203932,6021,229,6141,384,8951,544,5251,635,1041,176,921956,976784,454-98,072,874-97,663,990-101,745,168-101,916,7130-4,550,000-4,550,000-250,000-500,000-750,000-117,032,332-118,858,687-121,437,053000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
1,007,545
494,229
494,228
494,228494,2291,007,5450010000000000000000000000000000000000000
> Total Stockholder Equity
193,302,846
187,029,413
187,894,666
190,497,363
185,123,728
188,098,893
193,935,279
191,212,654
189,119,593
187,155,665
192,450,159
194,556,463
194,639,282
234,560,498
233,227,993
216,545,358
215,799,141
220,361,729
223,453,478
214,829,532
209,369,875
211,113,981
211,820,395
209,545,567
212,443,938
215,745,775
214,569,617
208,183,651
210,235,945
212,827,596
382,118,054
373,371,492
365,591,682
366,293,742
365,752,915
353,491,907
348,197,938
344,039,571
337,993,459
329,607,246
323,471,595
314,441,024
306,182,058
306,182,058314,441,024323,471,595329,607,246337,993,459344,039,571348,197,938353,491,907365,752,915366,293,742365,591,682373,371,492382,118,054212,827,596210,235,945208,183,651214,569,617215,745,775212,443,938209,545,567211,820,395211,113,981209,369,875214,829,532223,453,478220,361,729215,799,141216,545,358233,227,993234,560,498194,639,282194,556,463192,450,159187,155,665189,119,593191,212,654193,935,279188,098,893185,123,728190,497,363187,894,666187,029,413193,302,846
   Common Stock
20,266,085
21,016,600
21,016,600
21,016,600
21,016,600
21,797,150
21,797,150
21,797,150
21,797,150
22,609,000
22,609,000
22,609,000
22,609,000
26,492,495
26,492,495
26,492,495
26,492,495
26,492,495
26,492,495
26,492,495
26,492,495
26,492,495
26,492,495
26,492,495
26,492,495
26,492,495
26,492,495
27,592,495
27,592,495
27,592,495
27,592,495
27,592,495
27,592,495
27,592,495
27,592,495
27,592,495
27,592,495
27,592,495
27,592,495
0
0
27,592,495
0
027,592,4950027,592,49527,592,49527,592,49527,592,49527,592,49527,592,49527,592,49527,592,49527,592,49527,592,49527,592,49527,592,49526,492,49526,492,49526,492,49526,492,49526,492,49526,492,49526,492,49526,492,49526,492,49526,492,49526,492,49526,492,49526,492,49526,492,49522,609,00022,609,00022,609,00022,609,00021,797,15021,797,15021,797,15021,797,15021,016,60021,016,60021,016,60021,016,60020,266,085
   Retained Earnings 
164,950,037
0
10,335,695
0
0
0
0
0
0
0
0
0
0
0
0
146,603,547
147,898,761
151,351,152
154,255,530
148,218,139
148,220,946
150,318,911
151,150,771
147,841,325
144,563,530
146,999,854
147,831,734
146,462,504
148,713,143
150,519,125
154,271,361
156,595,484
152,884,907
153,274,725
151,302,049
139,159,599
133,826,800
129,227,817
120,774,565
115,830,156
108,795,404
99,797,123
91,745,520
91,745,52099,797,123108,795,404115,830,156120,774,565129,227,817133,826,800139,159,599151,302,049153,274,725152,884,907156,595,484154,271,361150,519,125148,713,143146,462,504147,831,734146,999,854144,563,530147,841,325151,150,771150,318,911148,220,946148,218,139154,255,530151,351,152147,898,761146,603,54700000000000010,335,6950164,950,037
   Capital Surplus 0000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000-11,687,629-11,687,629-11,687,629-11,687,629-11,687,629-11,687,629-11,687,629-11,687,629-11,687,629-11,687,629-11,687,629-11,687,629-11,687,629-11,687,629-11,677,093-11,677,093-11,677,093-11,677,093-11,667,713-11,667,713-11,667,713-11,659,121-11,659,121
   Other Stockholders Equity 0-17,806,66700-15,231,674-17,638,814-18,079,430-18,118,261-17,999,703-19,431,551-19,743,793-15,674,560-14,459,427-11,371,076-12,156,743-11,958,399-11,014,328-9,006,290-9,871,803-10,735,970-11,770,587-11,645,141-12,391,282-6,928,819-4,342,263-4,529,634-5,639,831-3,598,401000000000000000



Balance Sheet

Currency in KRW. All numbers in thousands.




Cash Flow

Currency in KRW. All numbers in thousands.




Income Statement

Currency in KRW. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue209,412,045
Cost of Revenue-126,403,617
Gross Profit83,008,42883,008,428
 
Operating Income (+$)
Gross Profit83,008,428
Operating Expense-251,261,635
Operating Income-41,849,590-168,253,207
 
Operating Expense (+$)
Research Development39,785,434
Selling General Administrative37,187,928
Selling And Marketing Expenses-
Operating Expense251,261,63576,973,362
 
Net Interest Income (+$)
Interest Income1,100,167
Interest Expense-1,074,265
Other Finance Cost-0
Net Interest Income25,902
 
Pretax Income (+$)
Operating Income-41,849,590
Net Interest Income25,902
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-43,095,359-41,849,590
EBIT - interestExpense = -1,074,265
-41,076,571
-40,002,306
Interest Expense1,074,265
Earnings Before Interest and Taxes (EBIT)--42,021,094
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-43,095,359
Tax Provision--2,072,148
Net Income From Continuing Ops-41,023,210-41,023,210
Net Income-41,076,571
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--25,902
 

Technical Analysis of Shin Poong Pharm.Co.Ltd.
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Shin Poong Pharm.Co.Ltd.. The general trend of Shin Poong Pharm.Co.Ltd. is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Shin Poong Pharm.Co.Ltd.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Shin Poong Pharm.Co.Ltd..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 20,050 < 20,050 < 22,150.

The bearish price targets are: 14,670 > 14,480 > 14,070.

Tweet this
Shin Poong Pharm.Co.Ltd. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Shin Poong Pharm.Co.Ltd.. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shin Poong Pharm.Co.Ltd. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Shin Poong Pharm.Co.Ltd.. The current macd is 1,042.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Shin Poong Pharm.Co.Ltd. price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Shin Poong Pharm.Co.Ltd.. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Shin Poong Pharm.Co.Ltd. price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Shin Poong Pharm.Co.Ltd. Daily Moving Average Convergence/Divergence (MACD) ChartShin Poong Pharm.Co.Ltd. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Shin Poong Pharm.Co.Ltd.. The current adx is 44.13.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Shin Poong Pharm.Co.Ltd. shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Shin Poong Pharm.Co.Ltd. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Shin Poong Pharm.Co.Ltd.. The current sar is 13,209.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Shin Poong Pharm.Co.Ltd. Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Shin Poong Pharm.Co.Ltd.. The current rsi is 64.15. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Shin Poong Pharm.Co.Ltd. Daily Relative Strength Index (RSI) ChartShin Poong Pharm.Co.Ltd. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Shin Poong Pharm.Co.Ltd.. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Shin Poong Pharm.Co.Ltd. price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Shin Poong Pharm.Co.Ltd. Daily Stochastic Oscillator ChartShin Poong Pharm.Co.Ltd. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Shin Poong Pharm.Co.Ltd.. The current cci is 119.51.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Shin Poong Pharm.Co.Ltd. Daily Commodity Channel Index (CCI) ChartShin Poong Pharm.Co.Ltd. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Shin Poong Pharm.Co.Ltd.. The current cmo is 27.51.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Shin Poong Pharm.Co.Ltd. Daily Chande Momentum Oscillator (CMO) ChartShin Poong Pharm.Co.Ltd. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Shin Poong Pharm.Co.Ltd.. The current willr is -48.84848485.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Shin Poong Pharm.Co.Ltd. is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Shin Poong Pharm.Co.Ltd. Daily Williams %R ChartShin Poong Pharm.Co.Ltd. Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Shin Poong Pharm.Co.Ltd..

Shin Poong Pharm.Co.Ltd. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Shin Poong Pharm.Co.Ltd.. The current atr is 1,160.

Shin Poong Pharm.Co.Ltd. Daily Average True Range (ATR) ChartShin Poong Pharm.Co.Ltd. Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Shin Poong Pharm.Co.Ltd.. The current obv is 37,507,296.

Shin Poong Pharm.Co.Ltd. Daily On-Balance Volume (OBV) ChartShin Poong Pharm.Co.Ltd. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Shin Poong Pharm.Co.Ltd.. The current mfi is 71.56.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Shin Poong Pharm.Co.Ltd. Daily Money Flow Index (MFI) ChartShin Poong Pharm.Co.Ltd. Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Shin Poong Pharm.Co.Ltd..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-11-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-11-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-23STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-07MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-08MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-02RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-21MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-25ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside

6.3. Candlestick Patterns

Shin Poong Pharm.Co.Ltd. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Shin Poong Pharm.Co.Ltd. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5064.146
Ma 20Greater thanMa 5013,195.500
Ma 50Greater thanMa 10012,632.200
Ma 100Greater thanMa 20012,849.700
OpenGreater thanClose16,150.000
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Shin Poong Pharm.Co.Ltd. with someone you think should read this too:
  • Are you bullish or bearish on Shin Poong Pharm.Co.Ltd.? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Shin Poong Pharm.Co.Ltd.? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Shin Poong Pharm.Co.Ltd.

I send you an email if I find something interesting about Shin Poong Pharm.Co.Ltd..


Comments

How you think about this?

Leave a comment

Stay informed about Shin Poong Pharm.Co.Ltd..

Receive notifications about Shin Poong Pharm.Co.Ltd. in your mailbox!